Home›Sodium Phosphate Dibasic Anhydrous Potassium Phosphate Monob›Sodium Phosphate Dibasic Anhydrous Potassium Phosphate Monob + Vitamin D

Does Sodium Phosphate Dibasic Anhydrous Potassium Phosphate Monob Interact with Vitamin D?

CDI records a moderate classification for Sodium Phosphate Dibasic Anhydrous Potassium Phosphate Monob and Vitamin D. The stored summary is: May antagonize the effects of phosphates in treatment of hypercalcemia. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity: Moderate
Management: Monitor for effects
Data Source: U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Sodium Phosphate Dibasic Anhydrous Potassium Phosphate Monob and your doctor is considering prescribing Vitamin D (or vice versa), make sure to:

Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
Ask whether the benefits of combining these medications outweigh the risks for your specific situation
Ask what symptoms to watch for that would indicate the interaction is causing problems
Ask whether any dosage adjustments are needed
Never stop or change either medication without first consulting your healthcare provider

💊 Sodium Phosphate Dibasic Anhydrous Potassium Phosphate Monob(K Phos Neutral)+💊 Vitamin D

Severity & Interaction Details

🟡

moderate

Be aware — moderate interaction

Documented interaction with manageable risk. May require dose adjustment or monitoring.

Severity scale

MinorContra

On record

Yes

Drug A class

—

Drug B class

—

Source

NLP:dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate

What this means in plain English

May antagonize the effects of phosphates in treatment of hypercalcemia.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

FDA

FDA Safety Alert: 5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius about Sodium Phosphate Dibasic Anhydrous Potassium Phosphate Monob · 2026-04

PubMed

Cloning, purification, crystallization and preliminary X-ray crystallographic analysis of a cyclophilin A-like protein from Piriformospora indica.about Sodium Phosphate Dibasic Anhydrous Potassium Phosphate Monob · 2012-06

PubMed

Follow-Up Care After Adult Lung Transplantation: Summary of an Evidence-Based Clinical Practice Guideline for German-Speaking Countries.about Vitamin D · 2026-06

PubMed

Effects of gliflozins on bone health of patients with chronic kidney disease: a systematic review.about Vitamin D · 2026-06

FDA

FDA Safety Alert: HALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Tablets, 1000 mg, 160-count bottle, Haleon, Waabout Vitamin D · 2026-06

Share this result:

WhatsApp Text / SMS Email

Also share on:X Facebook

Add more drugs

Check Sodium Phosphate Dibasic Anhydrous Potassium Phosphate Monob and Vitamin D against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.